Thank you for visiting this website to learn more about OPUS – a clinical study testing the potential of an investigational drug, cenerimod, for the treatment of Systemic Lupus Erythematosus (SLE).
Leaving the OPUS Study website
You are moving from OPUS Study website to an affiliated website or a third party website which is solely responsible for its content, including compliance with applicable guidelines in certain regions. Links to OPUS Study affiliated websites and third party websites are provided as a resource to our visitors and may not be governed by the same regulatory requirements that apply to this website. Affiliated website or Third party websites are subject to their own terms, notices and data protection practices. In addition, if Affiliated website or Third party websites are subject to the laws of other countries, regulatory requirements for data protection or medical practices may differ among countries and the information provided may not be suitable for use in your country.
Philippines 
日本語 